Stereotactic Radiation Therapy for HE2-positive Oligometastatic Breast Cancer
Conditions: HER2-positive Metastatic Breast Cancer; Oligometastatic Disease Interventions: Drug: Trastuzumab emtansine Sponsors: N.N. Petrov National Medical Research Center of Oncology Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | HER2 | Herceptin | Radiation Therapy | Research